Business Context and Reporting Period
This Form 8-K filing by iSpecimen Inc. (ISPC) covers the event date of November 19, 2025. The Company, an emerging growth company incorporated in Delaware, operates on The Nasdaq Capital Market. The report addresses a regulatory notice regarding stock listing compliance rather than operational or financial performance updates.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the closing bid price of the Company's common stock, which has been below the minimum $1.00 per share requirement for the prior 30 consecutive business days.
Material Changes
The material change reported is the Company's failure to satisfy Nasdaq Listing Rule 5550(a)(2) due to the sustained low stock price. Consequently, the Company is no longer in compliance with the Minimum Bid Price Requirement. There is no immediate effect on the listing status, and the stock continues to trade under the symbol "ISPC."
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has an initial 180-calendar-day period, ending May 18, 2026, to regain compliance.
- Regaining Compliance: Compliance is achieved if the closing bid price is at least $1.00 per share for a minimum of ten consecutive business days (or up to 20 days if required by Nasdaq Staff).
- Future Options: If compliance is not met by May 18, 2026, the Company may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of its intent to cure, which may include a reverse stock split.
- Risks: Failure to regain compliance within the applicable periods will result in delisting. The Company retains the right to appeal any delisting determination to a Nasdaq hearings panel.
- Management Commentary: Management intends to monitor the closing bid price and evaluate available options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of ISPC stock relative to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes intended to cure the deficiency.
- Track the Company's progress toward maintaining a $1.00+ closing price for ten consecutive business days before the May 18, 2026 deadline.
- Review subsequent filings for any updates on the Company's intent to utilize the second 180-day compliance period if the initial deadline is missed.